| 3.56 Real-Time Quote |  -0.14 / -3.78%Today’s Change | 1.63 Today|||52-Week Range 3.89 | +23.61% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $214.4M |
Company Description
Nanosphere, Inc. develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables simple, low cost and highly sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing and provides for multiple tests to be performed on a single platform, including both genomic and protein assays, from a single sample. The company breakthrough technology helps hospitals improve patient care and lowers costs by providing time-critical information, allowing earlier detection of disease and more targeted treatment. Nanosphere was founded by Chad A. Mirkin and Robert Letsinger in 2000 and is headquartered in Northbrook, IL.
Employees
Shareholders
| Mutual fund holders | 8.35% |
| Individual stakeholders | 37.66% |
| Other institutional | 13.93% |
Top Executives
| Michael K. McGarrity | President, Chief Executive Officer & Director |
| John Roger Moody, Jr., MBA | Chief Financial Officer, Secretary & Treasurer |
| Kenneth D. Bahk, PhD, MBA | Chief Strategy Officer |
| Winton G. Gibbons, MBA | Senior Vice President-Business Development |
| Bill Athenson, MBA | VP-International Marketing & Business Development |
.
